Stem cell study to prevent transplant complications withdrawn
NCT ID NCT06444022
First seen Apr 23, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study aimed to see if a special type of stem cell (hAESC) could safely prevent acute graft-versus-host disease (aGVHD) in people receiving a stem cell transplant for blood cancer. The trial was withdrawn before any participants were enrolled, so no results are available. The approach involved giving hAESCs through an IV and monitoring for side effects and GVHD rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-GRAFT-VERSUS-HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.